MORGAN STANLEY PLC/CALL/MERCK & CO./140/0.1/20.12.24 Share Price

Warrant

DE000MB16ZX3

Real-time Bid/Ask 13:15:58 08/07/2024 BST
0.27 EUR / 0.3 EUR +9.62% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./140/0.1/20.12.24
Current month-27.78%
1 month-33.33%
Date Price Change
08/07/24 0.27 +3.85%
05/07/24 0.26 +13.04%
04/07/24 0.23 -11.54%
03/07/24 0.26 -18.75%
02/07/24 0.32 -5.88%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 09:29 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB16ZX
ISINDE000MB16ZX3
Date issued 05/12/2022
Strike 140 $
Maturity 20/12/2024 (165 Days)
Parity 10 : 1
Emission price 0.72
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.87
Lowest since issue 0.061
Spread 0.02
Spread %6.67%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus